June 23, 2023
25 members of Congress send hormone letter to FDA
Twenty-five members of Congress signed a joint letter that was sent this week to FDA urging that the agency protect compounded hormone therapy and emphasizing the importance of continued patient access to compounded medications. The letter was anchored by Representative Jennifer Wexton (VA) and Representative Michael Burgess (TX).
Other signers on the letter include: Mark E. Amodei (NV), Brian Babin, D.D.S. (TX), Stephanie Bice (OK), Jerry L. Carl (AL), Earl L. “ Buddy” Carter (GA), Kathy Castor (FL), Henry Cuellar (TX), Diana DeGette (CO), Mario Diaz-Balart (FL), Neal P. Dunn, M.D. (FL), Brian Fitzpatrick (PA), Diana Harshbarger (TN), Clay Higgins (LA), Debbie Lesko (AZ), Marianne Miller-Meeks (IA), John R. Moolenaar (MI), Gregory F. Murphy, M.D. (NC), Gary J. Palmer (AL), Jimmy Panetta (CA), Mark Pocan (WI), C.A. Dutch Ruppersberger (MD), Austin Scott (GA), and Robert J. Wittman (VA).
The APC board and staff are very appreciative of the support the above have shown on our behalf. We ask our members to take a moment to reach out and thank their respective MOCs. These things don’t just happen, and we need to express our appreciation when they do.
Want to help save compounded hormone therapy? Invest here. Find marketing tools you can use here. And send your patients and prescribers to compounding.com to learn more and share testimonials.